🚀 VC round data is live in beta, check it out!
Hims Valuation Multiples
Discover revenue and EBITDA valuation multiples for Hims and similar public comparables like ACADIA Pharmaceuticals, Oscar Health, Ping An Healthcare, Doximity and more.
Hims Overview
About Hims
Hims & Hers Health Inc operates telehealth platforms, providing access to treatments for various chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. The company connects patients to licensed healthcare professionals who can prescribe medications, with prescriptions fulfilled online through licensed pharmacies. In addition, it offers access to various non-prescription health and wellness products. Through the Hims & Hers mobile applications, the company also offers access to educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Geographically, it derives maximum revenue from the USA.
Founded
2019
HQ
Employees
2.4K
Website
Financials (LTM)
EV
$4B
Hims Financials
Hims reported last 12-month revenue of $2B and EBITDA of $320M.
In the same LTM period, Hims generated $2B in gross profit, $320M in EBITDA, and $125M in net income.
Revenue (LTM)
Hims P&L
In the most recent fiscal year, Hims reported revenue of $2B and EBITDA of $318M.
Hims expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 74% | XXX | 74% | XXX | XXX | XXX |
| EBITDA | $320M | XXX | $318M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 14% | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $125M | XXX | $128M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $744M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Hims Stock Performance
Hims has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Hims' stock price is $16.48.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | 0.0% | XXX | XXX | XXX | $0.56 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHims Valuation Multiples
Hims trades at 1.8x EV/Revenue multiple, and 13.4x EV/EBITDA.
EV / Revenue (LTM)
Hims Financial Valuation Multiples
As of March 7, 2026, Hims has market cap of $4B and EV of $4B.
Equity research analysts estimate Hims' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hims has a P/E ratio of 29.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 1.8x | XXX | 1.8x | XXX | XXX | XXX |
| EV/EBITDA | 13.4x | XXX | 13.5x | XXX | XXX | XXX |
| EV/EBIT | 40.2x | XXX | 40.7x | XXX | XXX | XXX |
| EV/Gross Profit | 2.4x | XXX | 2.5x | XXX | XXX | XXX |
| P/E | 29.9x | XXX | 29.3x | XXX | XXX | XXX |
| EV/FCF | 60.8x | XXX | 74.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hims Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Hims Margins & Growth Rates
Hims' revenue in the last 12 month grew by 17%.
Hims' revenue per employee in the last FY averaged $1.0M.
Hims' rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hims' rule of X is 57% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Hims Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 3% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 57% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 39% | XXX | 39% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 9% | XXX | 12% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 69% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Hims Public Comps
See public comps and valuation multiples for other Mental Health Technology and Telemedicine & Virtual Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| ACADIA Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Oscar Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Ping An Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Doximity | XXX | XXX | XXX | XXX | XXX | XXX |
| JMDC | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hims M&A Activity
Hims acquired XXX companies to date.
Last acquisition by Hims was on XXXXXXXX, XXXXX. Hims acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Hims
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHims Investment Activity
Hims invested in XXX companies to date.
Hims made its latest investment on XXXXXXXX, XXXXX. Hims invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Hims
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hims
| When was Hims founded? | Hims was founded in 2019. |
| Where is Hims headquartered? | Hims is headquartered in United States. |
| How many employees does Hims have? | As of today, Hims has over 2K employees. |
| Who is the CEO of Hims? | Hims' CEO is Andrew Dudum. |
| Is Hims publicly listed? | Yes, Hims is a public company listed on NYSE. |
| What is the stock symbol of Hims? | Hims trades under HIMS ticker. |
| When did Hims go public? | Hims went public in 2021. |
| Who are competitors of Hims? | Hims main competitors are ACADIA Pharmaceuticals, Oscar Health, Ping An Healthcare, Doximity. |
| What is the current market cap of Hims? | Hims' current market cap is $4B. |
| What is the current revenue of Hims? | Hims' last 12 months revenue is $2B. |
| What is the current revenue growth of Hims? | Hims revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Hims? | Current revenue multiple of Hims is 1.8x. |
| Is Hims profitable? | Yes, Hims is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hims? | Hims' last 12 months EBITDA is $320M. |
| What is Hims' EBITDA margin? | Hims' last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Hims? | Current EBITDA multiple of Hims is 13.4x. |
| What is the current FCF of Hims? | Hims' last 12 months FCF is $71M. |
| What is Hims' FCF margin? | Hims' last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Hims? | Current FCF multiple of Hims is 60.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.